Author

C. Shorrock

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:cancer & tumor microenvironment· 1 Assay:DNA methylation· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Conforti· 3 shared B. Viscount· 3 shared E. Pinto· 3 shared E. Salvatori· 3 shared L. Aurisicchio· 3 shared L. Lione· 3 shared M. Compagnone· 3 shared D. G. Diel· 2 shared

Activity by Year

2022-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

A. Conforti

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A linear SARS-CoV-2 DNA vaccine candidate reduces virus shedding in ferrets

M. Martins, G. M. do Nascimento, A. Conforti, J. C. G. Noll, J. A. Impellizeri, E. Sanches, B. Wagner, L. Lione, E. Salvatori, E. Pinto, M. Compagnone, B. Viscount, J. Hayward, C. Shorrock, L. Aurisicchio, D. G. Diel

This study evaluates a linear SARS-CoV-2 DNA vaccine delivered via electroporation in ferrets, showing reduced virus shedding and immune responses.

bioRxiv · Sep 29, 2022 · PreprintImmunology

A linear DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain elicits protective immunity in domestic cats

A. Conforti, E. Sanchez, E. Salvatori, L. Lione, M. Compagnone, E. Pinto, F. Palombo, Y. Sun, B. Viscount, J. Hayward, C. Shorrock, D. G. Diel, J. A. Impellizeri, L. Aurisicchio

This study evaluates a linear DNA vaccine in domestic cats, showing it is safe and induces immune responses against SARS-CoV-2.

bioRxiv · Jul 20, 2022 · PreprintImmunology

Linear DNA amplicons as a novel cancer vaccine strategy

A. Conforti, E. Salvatori, L. Lione, M. Compagnone, E. Pinto, C. Shorrock, J. A. Hayward, Y. Sun, B. M. Liang, F. Palombo, B. Viscount, L. Aurisicchio

This study develops PCR-produced DNA amplicons as a cancer vaccine strategy, showing they elicit immune responses and reduce tumor growth when combined with immune-checkpoint inhibitors.

bioRxiv · Feb 9, 2022Immunology